Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014

Patompong Ungprasert, Matthew Koster, Wisit Cheungpasitporn, Karn Wijarnpreecha, Charat Thongprayoon, Paul T. Kroner

Research output: Contribution to journalArticle

Abstract

Objectives: To characterize inpatient burden, expenditures and association with comorbidities of polyarteritis nodosa (PAN). Methods: Patients with PAN were identified from the Nationwide Inpatient Sample (NIS) database for the year 2014 using ICD-9 diagnostic codes. The primary outcome was determining the inpatient prevalence of PAN in hospitalized patients in the US. Secondary outcomes included determining inpatient mortality, morbidity, comorbidities, hospital length of stay (LOS) and total hospital costs and charges. A cohort of patients without PAN was also identified from the same database to serve as comparators for analysis of comorbidities. Multivariate regression analysis was used to adjust for age, gender, ethnicity, comorbidities and hospital characteristics. Results: A total of 4,110 patients with PAN were included in the study. The mean age was 59.5 years and 61% were female. The inpatient prevalence of PAN was 11.6 cases per 100,000 discharges. Patients with PAN displayed increased adjusted odds of mortality (OR:1.35, p = 0.13), shock (OR:1.75, p<0.01), ICU admission (OR:1.88, p<0.01) and multiorgan failure (OR:3.12, p<0.01) compared to patients without PAN. Patients with PAN also displayed significantly higher hospital costs (additional adjusted mean [aAM]: $9,693, p<0.01), hospitalization charges (aAM: $34,273, p<0.01) and LOS (aAM: 4.1 days, p<0.01) compared to patients without PAN. Analysis of comorbidities found a significant association between PAN and venous thromboembolism, renal injury and sepsis. The main limitation of this study was reliance on accuracy of diagnostic coding. The high inpatient prevalence of PAN might have been inflated and we cannot be certain that the higher risk of comorbidities and expenditures were entirely attributable to PAN as some patients in this cohort may have other vasculitides. Conclusions: The inpatient prevalence of PAN is higher than what would be expected from the overall general prevalence. Hospitalizations of patients with PAN are associated with significantly higher rates of morbidity and expenditures.

Original languageEnglish (US)
JournalSeminars in Arthritis and Rheumatism
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Polyarteritis Nodosa
Comorbidity
Inpatients
Health Expenditures
Length of Stay
Hospital Costs
Hospitalization
Databases
Morbidity
Hospital Charges
Mortality
Venous Thromboembolism
International Classification of Diseases
Vasculitis

Keywords

  • Comorbidities
  • Epidemiology
  • Hospitalization
  • Polyarteritis nodosa

ASJC Scopus subject areas

  • Rheumatology
  • Anesthesiology and Pain Medicine

Cite this

Inpatient burden and association with comorbidities of polyarteritis nodosa : National Inpatient Sample 2014. / Ungprasert, Patompong; Koster, Matthew; Cheungpasitporn, Wisit; Wijarnpreecha, Karn; Thongprayoon, Charat; Kroner, Paul T.

In: Seminars in Arthritis and Rheumatism, 01.01.2019.

Research output: Contribution to journalArticle

Ungprasert, Patompong ; Koster, Matthew ; Cheungpasitporn, Wisit ; Wijarnpreecha, Karn ; Thongprayoon, Charat ; Kroner, Paul T. / Inpatient burden and association with comorbidities of polyarteritis nodosa : National Inpatient Sample 2014. In: Seminars in Arthritis and Rheumatism. 2019.
@article{18f327220538462499d42136cc0955f7,
title = "Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014",
abstract = "Objectives: To characterize inpatient burden, expenditures and association with comorbidities of polyarteritis nodosa (PAN). Methods: Patients with PAN were identified from the Nationwide Inpatient Sample (NIS) database for the year 2014 using ICD-9 diagnostic codes. The primary outcome was determining the inpatient prevalence of PAN in hospitalized patients in the US. Secondary outcomes included determining inpatient mortality, morbidity, comorbidities, hospital length of stay (LOS) and total hospital costs and charges. A cohort of patients without PAN was also identified from the same database to serve as comparators for analysis of comorbidities. Multivariate regression analysis was used to adjust for age, gender, ethnicity, comorbidities and hospital characteristics. Results: A total of 4,110 patients with PAN were included in the study. The mean age was 59.5 years and 61{\%} were female. The inpatient prevalence of PAN was 11.6 cases per 100,000 discharges. Patients with PAN displayed increased adjusted odds of mortality (OR:1.35, p = 0.13), shock (OR:1.75, p<0.01), ICU admission (OR:1.88, p<0.01) and multiorgan failure (OR:3.12, p<0.01) compared to patients without PAN. Patients with PAN also displayed significantly higher hospital costs (additional adjusted mean [aAM]: $9,693, p<0.01), hospitalization charges (aAM: $34,273, p<0.01) and LOS (aAM: 4.1 days, p<0.01) compared to patients without PAN. Analysis of comorbidities found a significant association between PAN and venous thromboembolism, renal injury and sepsis. The main limitation of this study was reliance on accuracy of diagnostic coding. The high inpatient prevalence of PAN might have been inflated and we cannot be certain that the higher risk of comorbidities and expenditures were entirely attributable to PAN as some patients in this cohort may have other vasculitides. Conclusions: The inpatient prevalence of PAN is higher than what would be expected from the overall general prevalence. Hospitalizations of patients with PAN are associated with significantly higher rates of morbidity and expenditures.",
keywords = "Comorbidities, Epidemiology, Hospitalization, Polyarteritis nodosa",
author = "Patompong Ungprasert and Matthew Koster and Wisit Cheungpasitporn and Karn Wijarnpreecha and Charat Thongprayoon and Kroner, {Paul T.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.semarthrit.2019.07.009",
language = "English (US)",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Inpatient burden and association with comorbidities of polyarteritis nodosa

T2 - National Inpatient Sample 2014

AU - Ungprasert, Patompong

AU - Koster, Matthew

AU - Cheungpasitporn, Wisit

AU - Wijarnpreecha, Karn

AU - Thongprayoon, Charat

AU - Kroner, Paul T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: To characterize inpatient burden, expenditures and association with comorbidities of polyarteritis nodosa (PAN). Methods: Patients with PAN were identified from the Nationwide Inpatient Sample (NIS) database for the year 2014 using ICD-9 diagnostic codes. The primary outcome was determining the inpatient prevalence of PAN in hospitalized patients in the US. Secondary outcomes included determining inpatient mortality, morbidity, comorbidities, hospital length of stay (LOS) and total hospital costs and charges. A cohort of patients without PAN was also identified from the same database to serve as comparators for analysis of comorbidities. Multivariate regression analysis was used to adjust for age, gender, ethnicity, comorbidities and hospital characteristics. Results: A total of 4,110 patients with PAN were included in the study. The mean age was 59.5 years and 61% were female. The inpatient prevalence of PAN was 11.6 cases per 100,000 discharges. Patients with PAN displayed increased adjusted odds of mortality (OR:1.35, p = 0.13), shock (OR:1.75, p<0.01), ICU admission (OR:1.88, p<0.01) and multiorgan failure (OR:3.12, p<0.01) compared to patients without PAN. Patients with PAN also displayed significantly higher hospital costs (additional adjusted mean [aAM]: $9,693, p<0.01), hospitalization charges (aAM: $34,273, p<0.01) and LOS (aAM: 4.1 days, p<0.01) compared to patients without PAN. Analysis of comorbidities found a significant association between PAN and venous thromboembolism, renal injury and sepsis. The main limitation of this study was reliance on accuracy of diagnostic coding. The high inpatient prevalence of PAN might have been inflated and we cannot be certain that the higher risk of comorbidities and expenditures were entirely attributable to PAN as some patients in this cohort may have other vasculitides. Conclusions: The inpatient prevalence of PAN is higher than what would be expected from the overall general prevalence. Hospitalizations of patients with PAN are associated with significantly higher rates of morbidity and expenditures.

AB - Objectives: To characterize inpatient burden, expenditures and association with comorbidities of polyarteritis nodosa (PAN). Methods: Patients with PAN were identified from the Nationwide Inpatient Sample (NIS) database for the year 2014 using ICD-9 diagnostic codes. The primary outcome was determining the inpatient prevalence of PAN in hospitalized patients in the US. Secondary outcomes included determining inpatient mortality, morbidity, comorbidities, hospital length of stay (LOS) and total hospital costs and charges. A cohort of patients without PAN was also identified from the same database to serve as comparators for analysis of comorbidities. Multivariate regression analysis was used to adjust for age, gender, ethnicity, comorbidities and hospital characteristics. Results: A total of 4,110 patients with PAN were included in the study. The mean age was 59.5 years and 61% were female. The inpatient prevalence of PAN was 11.6 cases per 100,000 discharges. Patients with PAN displayed increased adjusted odds of mortality (OR:1.35, p = 0.13), shock (OR:1.75, p<0.01), ICU admission (OR:1.88, p<0.01) and multiorgan failure (OR:3.12, p<0.01) compared to patients without PAN. Patients with PAN also displayed significantly higher hospital costs (additional adjusted mean [aAM]: $9,693, p<0.01), hospitalization charges (aAM: $34,273, p<0.01) and LOS (aAM: 4.1 days, p<0.01) compared to patients without PAN. Analysis of comorbidities found a significant association between PAN and venous thromboembolism, renal injury and sepsis. The main limitation of this study was reliance on accuracy of diagnostic coding. The high inpatient prevalence of PAN might have been inflated and we cannot be certain that the higher risk of comorbidities and expenditures were entirely attributable to PAN as some patients in this cohort may have other vasculitides. Conclusions: The inpatient prevalence of PAN is higher than what would be expected from the overall general prevalence. Hospitalizations of patients with PAN are associated with significantly higher rates of morbidity and expenditures.

KW - Comorbidities

KW - Epidemiology

KW - Hospitalization

KW - Polyarteritis nodosa

UR - http://www.scopus.com/inward/record.url?scp=85069882231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069882231&partnerID=8YFLogxK

U2 - 10.1016/j.semarthrit.2019.07.009

DO - 10.1016/j.semarthrit.2019.07.009

M3 - Article

AN - SCOPUS:85069882231

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

ER -